湖北兴发化工集团股份有限公司2025年年度报告深度解读

一、业绩概览与核心财务数据

• 营业收入：2025年公司实现营业收入292.99亿元，同比增长3.18%。
• 归母净利润：14.92亿元，同比下降6.83%。扣非后净利润14.30亿元，同比下降10.62%。
• 经营活动现金流：净额16.15亿元，同比增长1.68%。
• 总资产：520.23亿元，同比增长8.89%。
• 归母净资产：220.08亿元，同比增长2.54%。
• 基本每股收益：1.35元，同比下降6.90%。
• 加权平均净资产收益率：6.84%，同比下降0.75个百分点。

公司整体营收保持增长，但盈利能力出现下滑，主要源自产品价格波动和主营成本压力。

二、利润分配预案——高比例现金分红

• 2025年利润分配预案：每10股派发现金红利5元（含税），合计分红额约5.98亿元，分红占归母净利润的40.08%。
• 公司已连续三年高比例分红，近三年分红及回购总额约25.63亿元，分红比例高达171.11%。
• 若股本变动，分配比例不变，分红总额相应调整。

投资者需关注：持续高分红显示公司现金流充裕及对股东回报重视，或对股价形成支撑。

三、公司治理与风险提示

• 公司治理结构完善，严格按照《公司法》《证券法》及相关规则运行。
• 报告期内无控股股东、关联方非经营性占资，无违规对外担保。
• 内部控制审计、财务报表审计均获无保留意见。
• 重大风险提示：
  1. 安全环保风险：沿江化工企业受监管趋严，公司正持续加大投入与技改。
  2. 高端人才保障风险：研发与高管人才紧缺，正加大激励与人才引进。
  3. 产品价格波动风险：化工行业周期性明显，市场波动对业绩影响大，公司推进高端化转型以增强抗风险能力。

四、主营业务及行业情况

• 主营产品：磷矿石、硅矿石、特种化学品、农药、有机硅、肥料、新能源电池正极材料等，应用于食品、农业、半导体、汽车、建筑等领域。
• 行业分布：
  • 化工：主营收入220.99亿元，毛利率11.00%。
  • 矿山采选：主营收入35.05亿元，毛利率73.77%。
  • 商贸物流：主营收入32.80亿元，毛利率5.44%。
• 销售渠道：直销占比83%，经销占比16%。

五、重大投资与资本运作

• 2025年对外股权投资额16.37亿元。
• 重大在建项目：
  • 内蒙兴发20万吨/年工业硅项目（一期10万吨）累计投入2.03亿元。
  • 湖北兴友年产30万吨电池级磷酸铁二期项目累计投入0.17亿元。
• 持有中创新航港股，2025年公允价值浮盈2882万元。

投资者需关注：新能源材料及工业硅等新兴产业投入，有望成为公司未来业绩增长点。

六、可转债及股份变动

• 2022年发行28亿元可转换公司债券“兴发转债”，2025年末余额28.94亿元，信用评级AA+。
• 2025年累计转股2808股，2026年3月完成提前赎回，转债全部摘牌。
• 截至2026年4月2日，总股本达到12.02亿股。

投资者需关注：转债提前赎回表明公司股价表现坚挺，同时摊薄效应较小。

七、员工持股计划与激励机制

• 2025年公司实施员工持股计划，购入1308.33万股，占总股本1.19%。
• 公司高管实行KPI考核与多元激励，强化与公司业绩挂钩。

投资者需关注：员工持股及激励机制有助于激发活力，绑定核心团队利益。

八、环保与ESG信息披露

• 公司及20家主要子公司被纳入环境信息依法披露名单，ESG治理持续提升。
• 2025年发布环境、社会与公司治理（ESG）报告。

九、其他需关注事项

• 报告期内无重大诉讼、仲裁或违法违规处罚。
• 关键管理人员报酬2273.64万元。
• 公司未开展委托理财、委托贷款等高风险业务。

十、结论与投资建议

湖北兴发化工集团2025年保持收入增长，但受化工行业周期、原材料价格波动等影响，净利润下滑。公司持续推进高分红、员工持股、产业升级及新能源材料布局，显示出稳健的现金流与转型决心。投资者需密切关注公司在新能源、工业硅等新业务的业绩贡献，以及未来化工产品价格波动带来的影响。

重要提示：高比例现金分红、转债赎回、员工持股计划落地及新能源投资进展，均可能对公司未来股价形成实质影响。

免责声明：本文基于湖北兴发化工集团股份有限公司2025年年度报告整理，内容仅供投资者参考，不构成任何投资建议。投资有风险，决策需谨慎。

English Version

In-Depth Review: Hubei Xingfa Chemical Group 2025 Annual Report

1. Performance Overview & Key Financial Data

• Revenue: RMB 29.30 billion in 2025, up 3.18% YoY.
• Net Profit Attributable to Shareholders: RMB 1.49 billion, down 6.83% YoY. Net profit excluding non-recurring items: RMB 1.43 billion, down 10.62% YoY.
• Operating cash flow: RMB 1.62 billion, up 1.68% YoY.
• Total assets: RMB 52.02 billion, up 8.89% YoY.
• Net assets attributable to shareholders: RMB 22.01 billion, up 2.54% YoY.
• Basic EPS: RMB 1.35, down 6.90% YoY.
• ROE: 6.84%, down 0.75 percentage points.

Revenue growth continues, but profit margins declined due to cost and product price pressure.

2. Dividend Plan – High Payout Ratio

• 2025 Dividend Proposal: RMB 5 cash dividend per 10 shares (pre-tax), totaling approx. RMB 598 million, payout ratio 40.08% of net profit.
• Three-year cumulative payout and buyback amount: RMB 2.56 billion, payout ratio 171.11%.
• Payout ratio remains unchanged if share capital changes, total payout will be adjusted accordingly.

Investor focus: Sustained high payout signals strong cash flow and shareholder return, likely supporting share price.

3. Corporate Governance & Risk Alerts

• Solid governance structure, compliant with laws and regulations.
• No non-operating capital occupation by controlling shareholders or affiliates, no illegal guarantees.
• Both internal control and financial audits received unqualified opinions.
• Major risk alerts:
  1. Safety & environmental risk: Stringent regulation for river-side chemical plants; company increasing investment and automation.
  2. Talent risk: Shortage of top technical and management talents; company increasing incentives and recruitment.
  3. Product price volatility: High industry cyclicality; company pushing into high-value-added business to buffer volatility.

4. Main Business & Industry Position

• Main products: Phosphate ore, silicon ore, specialty chemicals, agrochemicals, organic silicon, fertilizers, battery materials. Applications: food, agriculture, semiconductors, automotive, construction, etc.
• Business breakdown:
  • Chemicals: Revenue RMB 22.10 billion, gross margin 11.00%.
  • Mining: Revenue RMB 3.50 billion, gross margin 73.77%.
  • Trade/logistics: Revenue RMB 3.28 billion, gross margin 5.44%.
• Sales channels: Direct 83%, distribution 16%.

5. Major Investment & Capital Moves

• Equity investments in 2025: RMB 1.64 billion.
• Key projects:
  • Inner Mongolia Xingfa 200kt/y industrial silicon (phase 1: 100kt) invested RMB 203 million.
  • Hubei Xingyou 300kt/y battery-grade iron phosphate (phase 2) invested RMB 16.5 million.
• Holding of CALB HK shares with fair value gain of RMB 28.82 million in 2025.

Investor focus: New energy and silicon projects could drive future earnings growth.

6. Convertible Bonds & Share Changes

• Issued RMB 2.8 billion “Xingfa Convertible Bond” in 2022, balance RMB 2.89 billion by end-2025, rated AA+.
• Converted 2,808 shares in 2025; early redemption completed March 2026, bond delisted.
• Total shares reached 1.20 billion by April 2026.

Investor focus: Early redemption reflects strong share price; dilution impact minimal.

7. Employee Shareholding & Incentive Mechanisms

• 2025 ESOP implemented, 13.08 million shares acquired (1.19% of share capital).
• Senior management subject to KPI and performance-based incentives.

Investor focus: ESOP and incentives enhance team cohesion and align interests.

8. ESG & Environmental Disclosure

• Company and 20 major subsidiaries included in mandatory environmental disclosure list; robust ESG.
• 2025 ESG report published.

9. Other Key Points

• No major litigation, arbitration, or violation during the period.
• Key management remuneration: RMB 22.74 million.
• No high-risk entrusted wealth management or loans.

10. Conclusion & Investment Takeaway

Hubei Xingfa Chemical saw revenue growth but profit decline in 2025, mainly due to sector headwinds. Strong cash flows, high dividend, ESOP, and new energy investments point to a stable yet transforming company. Investors should monitor the contribution from new energy and industrial silicon, as well as the effect of product price swings.

Key Price-sensitive Points: High cash dividend, convertible bond redemption, ESOP implementation, and progress in new energy investments are all likely to move the share price.

Disclaimer: The above is based on Hubei Xingfa Chemical Group’s 2025 Annual Report and is for reference only. It does not constitute investment advice. Please be aware of investment risks and make decisions prudently.

View 兴发集团 Historical chart here